vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
35.59
-1.66 (-4.46%)
Jan 16, 2026, 4:00 PM EST - Market closed
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $441.63 million as of January 16, 2026. Its market cap has increased by 305.37% in one year.
Market Cap
441.63M
Enterprise Value
343.49M
1-Year Change
305.37%
Ranking
Category
Stock Price
$35.59
Market Cap Chart
Since July 31, 2015, vTv Therapeutics's market cap has increased from $78.12M to $441.63M, an increase of 465.29%. That is a compound annual growth rate of 17.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 441.62M | -11.00% |
| Dec 31, 2025 | 496.22M | 445.90% |
| Dec 31, 2024 | 90.90M | 288.02% |
| Dec 29, 2023 | 23.43M | -56.62% |
| Dec 30, 2022 | 54.01M | -18.92% |
| Dec 31, 2021 | 66.61M | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |